Condensed Interim Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 2,653,197	$ 3,323,708
Restricted cash	1,000,000	1,000,000
Accounts receivable, net (note 19(b))	8,534,213	7,569,843
Prepaid expenses and other	4,107,378	3,079,785
Total current assets	16,294,788	14,973,336
Property, plant and equipment (note 5)	4,963,013	4,793,979
Intangible assets (note 6)	605,509	622,057
Finance right-of-use assets (note 7(a))	1,658,064	2,140,338
Operating right-of-use assets (note 7(b))	29,131,463	28,887,905
Total assets	52,652,837	51,417,615
Current liabilities:
Accounts payable and accrued liabilities (note 8)	16,235,405	13,701,630
Current portion of loans payable (note 9(a))	6,300,892	5,770,603
Current portion of finance lease liabilities (note 7(a))	547,440	622,730
Current portion of operating lease liabilities (note 7(b))	4,196,429	3,960,346
Current portion of shareholder loans (note 10)	507,524	505,161
Other payables (note 11)	2,565,269	5,730,781
Non-controlling interest loans (note 9(b))	64,767	63,174
Deferred and contingent consideration (note 12)	1,000,000	1,000,000
Advance for research collaboration (note 13)	1,300,000	1,300,000
Total current liabilities	32,717,726	32,654,425
Loans payable (note 9(a))	105,322,485	90,230,173
Finance lease liabilities (note 7(a))	144,660	235,107
Operating lease liabilities (note 7(b))	26,506,539	26,438,220
Shareholder loans (note 10)	2,928,411	2,807,480
Total liabilities	167,619,821	152,365,405
Shareholders' deficit:
Common shares (note 14)	121,236,710	120,741,061
Contributed surplus (note 15)	5,423,002	5,397,700
Deficit	(238,393,266)	(224,174,970)
Total shareholders' deficit excluding non-controlling interest	(111,733,554)	(98,036,209)
Non-controlling interest (note 23)	(3,233,430)	(2,911,581)
Total shareholders' deficit	(114,966,984)	(100,947,790)
Contingencies (note 16)
Total liabilities and shareholders' deficit	$ 52,652,837	$ 51,417,615